Patents by Inventor Anpurna Kaul

Anpurna Kaul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the isolation of novel oligospirostanoside
    Patent number: 6670459
    Abstract: The present invention relates to a process for the isolation of a novel oligospirostanoside structurally constructed as 3-0-[&agr;-L-rhamnopyranosyl-(1→2)-&agr;-L-rhamnopyranosyl-(1→4)-0-&bgr;-D-glucopyranosyl]-25(S)-5&bgr; spirostan-3&bgr;-ol isolated from Asparagus racemosus and biologically evaluated as a potent immunomodulatory agent.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: December 30, 2003
    Assignee: Zandu Pharmaceutical Works Ltd.
    Inventors: Sukhdev Swami Handa, Om Prakash Suri, Vishwa Nath Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Vikram Bhardwaj, Kasturi Lal Bedi, Anamika Khajuria, Anpurna Kaul, Girish G. Parikh, Prabhakar Kulhar, Ulhas Salunkhe, Raman Krishnamurthy
  • Oligospirostanoside, pharmaceutical composition containing novel oligospirostanoside and method for immunomodulation using said oligospirostanoside
    Patent number: 6649745
    Abstract: The present invention relates to a novel oligospirostanoside having the structure 3-0-[&agr;-L-rhamnopyranosyl-(1→2)-&agr;-L-rhamnopyranosyl-(1→4)-0-&bgr;-D-glucopyranosyl]-25(S)-5&bgr;-spirostan-3&bgr;-ol isolated from Asparagus racemosus and to a pharmaceutical composition containing the novel oligospirostanoside and to a method for immunomodulation using said oligospirostanoside by administering a pharmaceutically effective amount of said novel oligospirostanoside.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: November 18, 2003
    Assignees: Council of Scientific and Industrial Research, Department of Science and Technology, Zandu Pharmaceutical Works Limited
    Inventors: Sukhdev Swami Handa, Om Prakash Suri, Vishwa Nath Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Vikram Bhardwaj, Kasturi Lal Bedi, Anamika Khajuria, Anpurna Kaul, Girish G. Parikh, Prabhakar Kulhar, Ulhas Salunkhe, Raman Krishnamurthy
  • Process for the isolation of novel oligospirostanoside
    Publication number: 20030181395
    Abstract: The present invention relates to a process for the isolation of a novel oligospirostanoside structurally constructed as 3-0-[&agr;-L-rhamnopyranosyl-(1→2)-&agr;-L-rhamnopyranosyl-(1→4)-0-&bgr;-D-glucopyranosyl]-25(S)-spirostan-3&bgr;-ol isolated from Asparagus racemosus and biologically evaluated as a potent immunomodulatory agent.
    Type: Application
    Filed: March 20, 2002
    Publication date: September 25, 2003
    Inventors: Sukhdev Swami Handa, Om Prakash Suri, Vishwa Nath Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Vikram Bhardwaj, Kasturi Lal Bedi, Anamika Khajuria, Anpurna Kaul, Girish G. Parikh, Prabhakar Kulhar, Ulhas Salunkhe, Raman Krishnamurthy
  • NOVEL OLIGOSPIROSTANOSIDE, PHARMACEUTICAL COMPOSITION CONTAINING NOVEL OLIGOSPIROSTANOSIDE AND METHOD FOR IMMUNOMODULATION USING SAID OLIGOSPIROSTANOSIDE
    Publication number: 20030181396
    Abstract: The present invention relates to a novel oligospirostanoside having the structure 3-0-[&agr;-L-rhamnopyranosyl-(1→2)-&agr;-L-rhamnopyranosyl-(1→4)-0-&bgr;-D-glucopyranosyl]-25(S)-spirostan-3&bgr;-ol isolated from Asparagus racemosus and to a pharmaceutical composition containing the novel oligospirostanoside and to a method for immunomodulation using said oligospirostanoside by administering a pharmaceutically effective amount of said novel oligospirostanoside.
    Type: Application
    Filed: March 20, 2002
    Publication date: September 25, 2003
    Inventors: Sukhdev Swami Handa, Om Prakash Suri, Vishwa Nath Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Vikram Bhardwaj, Kasturi Lal Bedi, Anamika Khajuria, Anpurna Kaul, Girish G. Parikh, Prabhakar Kulhar, Ulhas Salunkhe, Raman Krishnamurthy
  • Pharmaceutical composition comprising extract from plant Cryptolepis buchanani for treating immunodeficiency
    Patent number: 6548086
    Abstract: Pharmaceutical composition and a method useful for treating immunodeficiency in animals or human beings, said composition comprising effective amount of the extract obtained from any part of plant Cryptolepis buchanani, either as such or its individual constituents singly or in composition with each other, optionally associated with pharmaceutically acceptable additives.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: April 15, 2003
    Assignee: Council of Scientific and Industrial Research
    Inventors: Rakesh Maurya, Anpurna Kaul, Sarang Bani, Usha Zutshi, Anamika Khajuria, Ajit Kumar Saxena, Lila Ram Manahas, Ashwani Kumar, Bal Krishnan Kapahi, Om Parkash Suri, Gulam Nabi Qazi